Study on Pharmacokinetics and Pharmacodynamics of high dose Meropenem.

Study on Pharmacokinetics and Pharmacodynamics of high dose Meropenem. - Study on Pharmacokinetics and Pharmacodynamics of high dose Meropenem.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017225

Enrollment

Registered

2015-04-21

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infectious disease

Interventions

Measurements of blood concentration of Meropenem and an evaluation of the efficacy and safety

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: In patients treated with Meropenem

Exclusion criteria

Exclusion criteria: Nothing

Design outcomes

Primary

Measure	Time frame
An evaluation of the efficacy and safety	—

Countries

Japan

Contacts

Public ContactOsamu Iketani

Keio University Hospital Center of Infectious Diseases and Infection Control

osamu.iketani@adst.keio.ac.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026